A Study to Compare PK, PD and Safety of the AD-214 and AD-2141

Clinical trial NCT05062876 · COMPLETED

Trial details

NCT number: NCT05062876
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2021-11-01
Primary completion: 2022-03-17
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.